Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 16.37B | 13.05B | 10.71B | 9.91B | 12.75B | 16.48B |
Gross Profit | 4.57B | 3.69B | 3.14B | 2.72B | 3.41B | 3.85B |
EBITDA | 1.88B | 1.35B | 1.09B | 781.65M | 1.57B | 1.90B |
Net Income | 1.12B | 655.25M | 451.16M | 109.97M | 642.84M | 827.00M |
Balance Sheet | ||||||
Total Assets | 15.55B | 17.65B | 14.68B | 14.05B | 14.92B | 16.15B |
Cash, Cash Equivalents and Short-Term Investments | 2.23B | 2.94B | 2.61B | 3.15B | 3.06B | 2.94B |
Total Debt | 4.43B | 5.01B | 4.76B | 5.32B | 5.74B | 6.04B |
Total Liabilities | 10.08B | 12.58B | 10.41B | 10.23B | 11.23B | 13.19B |
Stockholders Equity | 5.47B | 5.07B | 4.28B | 3.82B | 3.68B | 2.97B |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 154.01M | 232.46M | 660.14M | 662.62M | 991.00M |
Operating Cash Flow | 0.00 | 348.01M | 327.16M | 754.47M | 792.98M | 1.21B |
Investing Cash Flow | 0.00 | -188.70M | -209.00M | -86.75M | -132.35M | -240.00M |
Financing Cash Flow | 0.00 | 169.62M | -651.78M | -576.77M | -552.72M | -938.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
79 Outperform | ¥4.31B | 4.27 | 2.04% | 17.94% | 52.80% | ||
78 Outperform | ¥5.66B | 9.33 | 2.78% | 6.71% | 1.17% | ||
63 Neutral | $34.16B | 5.78 | -11.85% | 1.82% | 5.31% | -18.32% | |
59 Neutral | ¥4.40B | ― | 1.96% | 4.48% | 39.17% | ||
56 Neutral | ¥2.46B | ― | 2.75% | -9.40% | -269.39% | ||
48 Neutral | ¥4.74B | ― | 2.01% | -32.99% | -1509.50% | ||
31 Underperform | ¥5.41B | ― | ― | 2.37% | -83.58% |